Post Profile






Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy

CAMBRIDGE, Mass. (May 22, 2012) – Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part of this system, heat shock protein 90 (HSP90) has been shown to help malignant cells accommodate the genetic changes and profound disturbances in normal biology that occur in cancers.
read more

share

Related Posts:


Breast Cancer Clinical Trial to Test Combination of Heat Shock Protein Inhibitor and Hormonal Therapy

Health : Newswise Medical News (3 years ago)

A clinical trial involving collaboration between researchers at Whitehead Institute and Dana Farber Cancer Institute is now enrolling patients with recurrent or metastatic estrogen receptor-positive (ER+) breast cancer. The trial wi... Read Post

Rutgers Cancer Institute of New Jersey Offers Clinical Trial for Solid Tumors with Novel Small Molecule Agent

Health : Newswise Medical News (22 hours ago)

Rutgers Cancer Institute of New Jersey is offering a clinical trial examining the investigational treatment known as ONC201 in patients with solid tumors whose cancer no longer responds to standard therapy. Prior research on the stu... Read Post

Combo Of Heat Shock Protein Inhibitor And Hormonal Therapy Being Tested In Breast Cancer Clinical Trial

Health : Medical News Today (3 years ago)

Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part of this... Read Post

Comments


Copyright © 2015 Regator, LLC